EVOLUS, INC. Operating Lease Cost
EVOLUS, INC. (EOLS) reported Operating Lease Cost of $559.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-08-05
- EVOLUS, INC. operating lease, cost for the quarter ending 2026-06-30 was $559.00K, a 4.49% increase year-over-year.
- EVOLUS, INC. operating lease, cost for the quarter ending 2026-03-31 was $559.00K, a 18.68% increase year-over-year.
- EVOLUS, INC. operating lease, cost for the quarter ending 2025-12-31 was $563.00K, a 19.53% increase year-over-year.
- EVOLUS, INC. operating lease, cost for the quarter ending 2025-09-30 was $560.00K, a 44.70% increase year-over-year.
- EVOLUS, INC. operating lease, cost for fiscal 2025 was $2.13M, a 39.52% increase from fiscal 2024.
- EVOLUS, INC. operating lease, cost for fiscal 2024 was $1.53M, a 31.10% increase from fiscal 2023.
- EVOLUS, INC. operating lease, cost for fiscal 2023 was $1.16M, a 7.38% increase from fiscal 2022.
- EVOLUS, INC. operating lease, cost for fiscal 2022 was $1.08M, a 1.78% increase from fiscal 2021.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $559.00K 10-Q · filed 2026-08-05 | $1.12M 10-Q · filed 2026-08-05 | $1.68M derived: sum of 3 quarters · filed 2026-08-05 | $2.24M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $559.00K 10-Q · filed 2026-05-04 | $1.12M derived: sum of 2 quarters · filed 2026-05-04 | $1.68M derived: sum of 3 quarters · filed 2026-05-04 | $2.22M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $563.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $1.12M derived: sum of 2 quarters · filed 2026-03-03 | $1.66M derived: sum of 3 quarters · filed 2026-08-05 | $2.13M 10-K · filed 2026-03-03 |
| 2025-09-30 | $560.00K 10-Q · filed 2025-11-05 | $1.09M derived: sum of 2 quarters · filed 2026-08-05 | $1.57M 10-Q · filed 2025-11-05 | $2.04M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $535.00K 10-Q · filed 2026-08-05 | $1.01M 10-Q · filed 2026-08-05 | $1.48M derived: sum of 3 quarters · filed 2026-08-05 | $1.86M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $471.00K 10-Q · filed 2026-05-04 | $942.00K derived: sum of 2 quarters · filed 2026-05-04 | $1.33M derived: sum of 3 quarters · filed 2026-05-04 | $1.67M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $471.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $858.00K derived: sum of 2 quarters · filed 2026-03-03 | $1.20M derived: sum of 3 quarters · filed 2026-03-03 | $1.53M 10-K · filed 2026-03-03 |
| 2024-09-30 | $387.00K 10-Q · filed 2025-11-05 | $727.00K derived: sum of 2 quarters · filed 2025-11-05 | $1.05M 10-Q · filed 2025-11-05 | $1.39M derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-06-30 | $340.00K 10-Q · filed 2025-08-05 | $669.00K 10-Q · filed 2025-08-05 | $999.00K derived: sum of 3 quarters · filed 2026-03-03 | $1.28M derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-03-31 | $328.00K 10-Q · filed 2025-05-07 | $659.00K derived: sum of 2 quarters · filed 2026-03-03 | $945.00K derived: sum of 3 quarters · filed 2026-03-03 | $1.22M derived: sum of 4 quarters · filed 2026-03-03 |
| 2023-12-31 | $331.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $617.00K derived: sum of 2 quarters · filed 2026-03-03 | $890.00K derived: sum of 3 quarters · filed 2026-03-03 | $1.16M 10-K · filed 2026-03-03 |
| 2023-09-30 | $286.00K 10-Q · filed 2024-11-06 | $559.00K derived: sum of 2 quarters · filed 2024-11-06 | $833.00K 10-Q · filed 2024-11-06 | $1.10M derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-06-30 | $273.00K 10-Q · filed 2024-07-31 | $547.00K 10-Q · filed 2024-07-31 | $819.00K derived: sum of 3 quarters · filed 2025-03-04 | $1.09M derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-03-31 | $273.00K 10-Q · filed 2024-05-07 | $546.00K derived: sum of 2 quarters · filed 2025-03-04 | $819.00K derived: sum of 3 quarters · filed 2025-03-04 | $1.09M derived: sum of 4 quarters · filed 2025-03-04 |
| 2022-12-31 | $273.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $546.00K derived: sum of 2 quarters · filed 2025-03-04 | $815.00K derived: sum of 3 quarters · filed 2025-03-04 | $1.08M 10-K · filed 2025-03-04 |
| 2022-09-30 | $273.00K 10-Q · filed 2023-11-07 | $542.00K derived: sum of 2 quarters · filed 2023-11-07 | $811.00K 10-Q · filed 2023-11-07 | $1.08M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $269.00K 10-Q · filed 2023-08-02 | $538.00K 10-Q · filed 2023-08-02 | $806.00K derived: sum of 3 quarters · filed 2023-08-02 | $1.07M derived: sum of 4 quarters · filed 2023-08-02 |
| 2022-03-31 | $269.00K 10-Q · filed 2023-05-09 | $537.00K derived: sum of 2 quarters · filed 2023-05-09 | $805.00K derived: sum of 3 quarters · filed 2023-05-09 | $1.07M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $268.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $536.00K derived: sum of 2 quarters · filed 2023-03-08 | $800.00K derived: sum of 3 quarters · filed 2023-03-08 | $1.06M 10-K · filed 2023-03-08 |
| 2021-09-30 | $268.00K 10-Q · filed 2022-11-08 | $532.00K derived: sum of 2 quarters · filed 2022-11-08 | $797.00K 10-Q · filed 2022-11-08 | $1.06M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $264.00K 10-Q · filed 2022-08-02 | $529.00K 10-Q · filed 2022-08-02 | $796.00K derived: sum of 3 quarters · filed 2022-08-02 | $1.06M derived: sum of 4 quarters · filed 2022-08-02 |
| 2021-03-31 | $265.00K 10-Q · filed 2022-05-10 | $532.00K derived: sum of 2 quarters · filed 2022-05-10 | $798.00K derived: sum of 3 quarters · filed 2022-05-10 | $1.07M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $267.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $533.00K derived: sum of 2 quarters · filed 2022-03-03 | $806.00K derived: sum of 3 quarters · filed 2022-03-03 | $1.08M 10-K · filed 2022-03-03 |
| 2020-09-30 | $266.00K 10-Q · filed 2021-11-02 | $539.00K derived: sum of 2 quarters · filed 2021-11-02 | $813.00K 10-Q · filed 2021-11-02 | $1.09M derived: sum of 4 quarters · filed 2021-11-02 |
| 2020-06-30 | $273.00K 10-Q · filed 2021-08-04 | $547.00K 10-Q · filed 2021-08-04 | $829.00K derived: sum of 3 quarters · filed 2021-08-04 | $1.13M derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | $274.00K 10-Q · filed 2021-05-12 | $556.00K derived: sum of 2 quarters · filed 2021-05-12 | $853.00K derived: sum of 3 quarters · filed 2021-05-12 | $1.12M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $282.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $579.00K derived: sum of 2 quarters · filed 2021-03-25 | $846.00K derived: sum of 3 quarters · filed 2021-03-25 | $1.08M 10-K · filed 2021-03-25 |
| 2019-09-30 | $297.00K 10-Q · filed 2020-10-29 | $564.00K derived: sum of 2 quarters · filed 2020-10-29 | $798.00K 10-Q · filed 2020-10-29 | |
| 2019-06-30 | $267.00K 10-Q · filed 2020-08-10 | $501.00K 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | $234.00K 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |